Cargando…
COVID-19 disease and immune dysregulation
The SARS-CoV-2 virus has complex and divergent immune alterations in differing hosts and over disease evolution. Much of the nuanced COVID-19 disease immune dysregulation was originally dominated by innate cytokine changes, which has since been replaced with a more complex picture of innate and adap...
Autores principales: | Davitt, Ethan, Davitt, Colin, Mazer, Monty B., Areti, Sathya S., Hotchkiss, Richard S., Remy, Kenneth E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9568269/ https://www.ncbi.nlm.nih.gov/pubmed/36494149 http://dx.doi.org/10.1016/j.beha.2022.101401 |
Ejemplares similares
-
In Vitro–Administered Dexamethasone Suppresses T Cell Function With Reversal by Interleukin-7 in Coronavirus Disease 2019
por: Mazer, Monty B., et al.
Publicado: (2021) -
Dysregulation of the Leukocyte Signaling Landscape during Acute COVID-19
por: Turnbull, Isaiah R., et al.
Publicado: (2021) -
Dysregulation of the leukocyte signaling landscape during acute COVID-19
por: Turnbull, Isaiah R., et al.
Publicado: (2022) -
What's New in Critical Illness and Injury Science? Alteplase for severe coronavirus disease 2019: Not quite ready to clot bust just hypoxemia
por: Areti, Sathya, et al.
Publicado: (2022) -
In Covid-19 Infection, Plasma Extracellular Vesicle Tissue Factor Activity Does Not Correlate with D-Dimer Levels
por: Girard, Thomas J., et al.
Publicado: (2021)